Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Amryt to sell Aegerion's Lojuxta in certain European and Middle Eastern countries

Executive Summary

Novelion Therapeutics Inc.'s subsidiary Aegerion Pharmaceuticals Inc. licensed rare disease-focused Amryt Pharma PLC exclusive rights to promote and distribute Lojuxta (lomitapide) capsules in the European Economic Area, Switzerland, Turkey, and certain Middle Eastern and North African countries including Israel.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Royalty or Profit Split Information
    • Intra-Biotech Deal
    • Marketing (Licensing)

Related Companies